Pharmaceutical Cleanroom ESD Flooring

Systems: Static dissipative ESD epoxy (10⁶–10⁹ Ω) for standard pharma cleanroom work; conductive ESD epoxy (below 1.0 × 10⁶ Ω) for flammable solvent exposure zones
ESD Compliance:
- – ANSI/ESD S20.20-2021 program standard
- – STM 7.1 resistance testing (Rg and Rtt)
- – STM 97.1 + 97.2 body voltage verification
- – IEC 61340-5-1 international ESD program
Pharma Regulatory:
- – FDA facility design
- – cGMP (21 CFR Part 211)
- – USP <797> sterile compounding
- – USP <800> hazardous drug handling
- – ISO 14644-1 Class 5, 6, 7, 8
System Thickness: 30–60 mils standard ESD epoxy
Service Life: 25+ years
Pricing: $3.34–13.55/sqft installed, depending on system thickness, vertical, and substrate condition. Pharma cleanroom work tends toward the higher end due to integral cove base, low-VOC topcoat, phased install, and validation documentation overhead. Range from real bid data on 250+ commercial ESD projects.
Lead Time: 1–3 weeks from contract execution, driven by material availability
Cure-and-Test Window: 24–72 hours from final coat to STM 7.1 resistance verification
Installation:
- – Phased install around live pharma operations
- – Integral cove base for sterile wall-floor transitions
- – Atmosphere-controlled install protocols
- – Weekend and night shutdown windows available
Documentation:
- – S20.20 closeout package (STM 7.1, 97.1, 97.2 logs)
- – IQ / OQ / PQ validation package
- – Material chain of custody and batch certifications
- – Product data sheets for every system component
Manufacturer Authorizations: Authorized SW + PIP + Sika installer (Sikafloor PurCem ESD and Sikafloor ESD product lines)
Crew Structure: In-house W-2 crews mobilize nationwide from 9 operating locations. Trained, insured, and accountable.
Pharma Client History: Lilly, AbbVie [STAKEHOLDER: TBD]
Since: 1999

Phone: +1 (844) 687-1961

Email: projects@craftsmanconcretefloors.com

Pharmaceutical cleanroom ESD flooring is a static-controlled epoxy system installed where ANSI/ESD S20.20 and the pharma regulatory framework — FDA, cGMP, USP <797>, USP <800>, and ISO 14644 — apply to the same floor at the same time. Most ISO Class 5-7 pharma cleanroom work specifies static dissipative epoxy at 10⁶ to 10⁹ ohms (Rg) per S20.20, with conductive epoxy reserved for narrow exception cases involving flammable solvent handling in hazardous drug compounding. The spec engineer’s problem is not picking one regulatory track. It is coordinating both, because a floor that passes resistance testing but fails cleanability — or passes cleanability but drifts out of the 10⁶-10⁹ Ω band — is an audit fail.

Pharma cleanroom ESD epoxy is not generic cleanroom epoxy with an ESD label, and it is not generic ESD epoxy installed inside a cleanroom envelope. Generic cleanroom epoxy without static control leaves dispensing scales, fill-finish lines, and electronic measurement equipment exposed to charge buildup. Generic ESD epoxy without integral cove base, low-VOC topcoat chemistry, and atmosphere-controlled install protocols will not pass a cGMP audit on cleanability or particle generation. Pharmaceutical cleanroom flooring written as a cGMP cleanroom flooring spec or an FDA compliant cleanroom flooring spec has to clear both audits on the same system. The category is the discipline of running both tracks through one floor system, one documentation package, and one phased install plan.

Our Clients

Dual Regulatory Track — ANSI/ESD S20.20 Plus FDA/cGMP/USP

The four subheads below trace what each framework actually demands of the floor. S20.20 sets resistance bands, body voltage limits, grounding network, and periodic verification. ISO 14644 sets particle generation and seam-free construction by class. USP <797> sets cleanability and cove base detail for sterile compounding. USP <800> adds containment-focused detail for hazardous drug handling, with a conductive-system trigger when flammable solvents enter the room.

ANSI/ESD S20.20 — Static Control Program Inside the Cleanroom Envelope

S20.20 program requirements do not relax inside a cleanroom envelope. The static dissipative range is 10⁶ to 10⁹ Ω (Rg) per S20.20. Body voltage stays under 100 V per STM 97.1, and under 100 V with the facility’s specified ESD footwear per STM 97.2. The copper grounding strap network gets installed below the primer layer, terminated to facility ground at the perimeter, with strap spacing matched to the program documentation. STM 7.1 resistance verification — point-to-point and point-to-ground — happens after the 24-72 hour cure-and-test window. The closeout package goes into the same binder the EHS lead hands to the auditor.

ISO 14644 Classifications — Class 5 Through Class 8 Flooring Implications

ISO 14644-1 Class 5, 6, 7, and 8 each carry different particle concentration thresholds, and the flooring spec changes with class. Class 5 environments (fill-finish, aseptic processing) require monolithic seam-free surfaces with low-VOC topcoats and integral cove base — no panel seams, no expansion joints inside the envelope. Class 6 and 7 environments allow slightly looser topcoat selection but still demand integral cove base and verified low particle generation. Class 8 (gowning rooms, MAL/PAL vestibules) tolerates standard cove base detail but still rules out anything that sheds particles under traffic — which rules out polished concrete, sealed concrete, and resilient ESD tile.

USP <797> — Sterile Compounding Flooring Requirements

USP <797> sterile compounding environments require flooring that holds up to repeat decontamination per the facility’s cleaning protocol, transitions to wall via integral cove base for surface continuity, and contributes no particle load above the ISO classification of the buffer area or ante-area. A USP 797 flooring spec written this way pairs static dissipative epoxy at 10⁶-10⁹ Ω, monolithic, with integral cove base, low-VOC chemistry, and verified resistance per STM 7.1. The closeout package documents both the ANSI/ESD S20.20 compliant side and the cleanability and material data side a USP <797> inspector will ask for.

USP <800> — Hazardous Drug Handling Flooring Requirements

USP <800> environments — oncology compounding, anti-neoplastic drug handling, hazardous drug receipt and storage — carry the USP <797> flooring baseline plus containment-focused detail at floor penetrations, equipment pads, and negative-pressure room transitions. A USP 800 flooring spec for a hazardous drug compounding suite with flammable solvent exposure may call for conductive epoxy below 1.0 × 10⁶ Ω instead of static dissipative, paired with the facility’s spark-control program. ISO 14644 cleanroom flooring requirements stack on top — the room’s particle classification still governs topcoat selection and cove base detail regardless of which USP chapter applies. The selection is driven by the solvent list and the EHS team’s hazardous-area classification, not by a default flooring preference.

System Selection for Pharmaceutical Cleanroom Work

Most pharma cleanrooms spec static dissipative epoxy. Conductive epoxy shows up in a narrow band of hazardous drug compounding suites and certain biologics fill suites with flammable solvent exposure. The selection is a function of the EHS team’s S20.20 program document, the USP chapter that governs the room, and the hazardous-area classification for the solvent list — not a flooring contractor’s preference.

Static Dissipative — 10⁶ to 10⁹ Ohms per S20.20

Static dissipative epoxy at 10⁶ to 10⁹ Ω (Rg) is the standard pharma cleanroom spec. The resistance band controls charge dissipation slowly enough to protect personnel from grounding-fault current and fast enough to protect ESD-sensitive equipment in dispensing, fill-finish, and packaging zones. STM 7.1 verifies Rg and Rtt readings after 24-72 hours of cure. STM 97.1 and STM 97.2 verify walking body voltage stays under 100 V with the facility’s specified footwear. The system passes a standard cGMP audit on cleanability when paired with integral cove base and a low-VOC topcoat.

Conductive — Below 1.0 × 10⁶ Ohms for Flammable Solvent Exposure

Conductive epoxy below 1.0 × 10⁶ Ω is specified when the room sits inside a Class I Division 2 hazardous-area classification, when the solvent list includes ethanol, isopropanol, methanol, or other flammable carriers in process volumes, or when the EHS team’s S20.20 program calls for conductive instead of dissipative based on charge-generation modeling. The aggressive dissipation profile demands the facility’s grounding network be verified end-to-end — conductive flooring without a verified ground path is a code violation, not a safety upgrade.

Low-VOC Topcoat Chemistry for Atmosphere-Controlled Environments

Standard ESD epoxy topcoats often carry VOC profiles that fail inside an atmosphere-controlled cleanroom envelope during cure. Pharma cleanroom ESD specs call for low-VOC topcoat chemistry sourced from the SW, PIP, and Sika ESD product lines, so the install does not contaminate adjacent live rooms through the HVAC return path. Topcoat selection is locked at the spec stage, before the COI goes in, so the facility’s environmental monitoring program does not flag a particle or VOC excursion during the install window.

Request a Proposal

Submit project parameters for preliminary analysis. Commercial estimates typically returned within 24 hours.

Installation Around Live Pharmaceutical Operations

Most pharma facilities cannot fully shut down for ESD flooring installation. Phased install methodology is the default. Phase boundaries are planned around production line shutdowns the facility has already scheduled, COIs go in before mobilization, and atmosphere control inside the work zone prevents contamination of adjacent live cleanrooms.

Phased Install Methodology — Phase Boundaries Around Production Shutdowns

A phased ESD install on a live pharma site is zone-by-zone work over multiple weekends or scheduled production-line down windows. The phase plan gets built off the facility’s production calendar, with hard boundaries between active and inactive zones — temporary wall partitions, dedicated HVAC return isolation, separate ingress and egress routes for the crew. Each zone moves through prep, primer, body coat, topcoat, and the 24-72 hour cure-and-test window before STM 7.1 resistance verification. The next zone starts after the previous one is back in service.

Integral Cove Base for Sterile Wall-Floor Transitions

Integral cove base — a continuous epoxy radius poured into the wall-floor transition, not an applied vinyl or rubber base set on top of a finished floor — is the cGMP-cleanable detail pharma cleanrooms require. The cove base is part of the same monolithic system as the floor field, so there is no seam at the wall, no crevice for biofilm or particle accumulation, and no transition for a USP <797> or USP <800> decontamination protocol to fail at. Cove base height is specified by the cleanroom design — typically 4 to 6 inches in Class 7 and 8 environments, sometimes taller in Class 5 and 6.

Atmosphere Control During Install — Particle, Temperature, and Humidity Discipline

Crews working inside or adjacent to a live cleanroom envelope hold the install zone to defined temperature, humidity, and particle count limits during prep, application, and cure. HVAC isolation between the work zone and active rooms gets verified before mobilization. Material staging and waste removal follow the facility’s cleared-environment access protocols. The crew is in pharma-appropriate gowning, with COI submitted, background checks cleared, and ingress through the facility’s defined access point — not through whatever door is closest.

Compliance Testing and Validation Documentation

A pharma cleanroom ESD install produces two documentation tracks: the S20.20 closeout package (STM 7.1 resistance logs, STM 97.1 and 97.2 body voltage data, grounding network verification) and the validation package (IQ, OQ, PQ) the facility’s quality system needs to add the floor to its asset register. Both ship together.

ESD Compliance Testing — STM 7.1, STM 97.1, STM 97.2

STM 7.1 resistance verification runs after the 24-72 hour cure-and-test window. Readings are taken point-to-point (Rtt) and point-to-ground (Rg) on a grid across the installed zone, with the data logged into the closeout package against the S20.20 program threshold. STM 97.1 verifies walking body voltage under 100 V without footwear control, STM 97.2 verifies under 100 V with the facility’s specified ESD footwear. The data goes into the same package the EHS lead hands to the S20.20 auditor and the cGMP inspector.

Validation Documentation — IQ, OQ, PQ

The IQ package documents installed system components — primer SKU, body coat SKU, topcoat SKU, grounding strap copper gauge, cove base detail — against the approved spec. OQ shifts to functional verification: resistance readings, body voltage readings, ground continuity, each logged against the program threshold. PQ covers performance against the facility’s intended use, with cleanability protocol references and material compatibility data folded in. The whole package is built to drop into the facility’s existing quality system, not handed over as a parallel binder the QA team has to re-format.

FDA Audit Trail — Chain of Custody, Batch Certs, Product Data Sheets

The closeout package includes material chain-of-custody from manufacturer to install zone, batch certifications for each container of primer, body coat, and topcoat used on the project, and current product data sheets for every system component. When the FDA inspector asks “what is on this floor and where did it come from,” the answer is in the binder. The audit trail is built during the install, not reconstructed after.

Why Craftsman for Pharmaceutical Cleanroom ESD Work

Pharma cleanroom ESD work demands fluency in both regulatory tracks at once, plus a crew structure that can hold to atmosphere-controlled install discipline across a phased schedule. Craftsman is built around in-house W-2 crews mobilizing nationwide from 9 operating locations, with authorized installer credentials at the three manufacturer programs whose products show up on pharma cleanroom specs.

W-2 Installers, Not 1099 Day-Labor

The crews on a Craftsman pharma cleanroom job are W-2 employees, trained on the gowning and atmosphere protocols Block C describes. Not 1099 day-labor pulled together for the project. Trained, insured, and accountable to the facility through Craftsman’s chain of command. That structure is what makes a phased schedule hold across multiple weekends — same crew through prep, primer, body coat, topcoat, and the STM 7.1 verification step, with the validation paperwork carried forward by the same hands that did the work rather than re-introduced at every rotation.

Authorized SW + PIP + Sika Installer

Craftsman is an Authorized SW, PIP, and Sika installer — all three credentials at parity. Sika authorization covers the Sikafloor PurCem ESD and Sikafloor ESD product lines (post-MBCC family). SW HPF and PIP ESD product lines round out the pharma cleanroom system options. When the spec calls out a specific manufacturer system, the install proceeds under that program, and warranty registration goes to the manufacturer rep with the same batch certs, primer/body/topcoat lot numbers, and STM 7.1 logs the facility’s QA team gets in the validation package — one documentation track, two recipients.

Pharma Project History and Phased Install Discipline

Pharma client history includes Lilly and AbbVie. The Dallas 34,000 sq ft Fortune 500 ESD epoxy project (Tier-1 electronics QA environment, phased install around live operations) and the Houston 67,000 sq ft hyperscale-grade ESD epoxy project are scale-and-discipline analogs in the portfolio — both ran through the same multi-weekend phasing, atmosphere control, and same-crew documentation continuity a pharma cleanroom retrofit requires.

Frequently Asked Questions

Most pharmaceutical cleanroom work specifies static dissipative epoxy at 10⁶ to 10⁹ ohms (Rg) per ANSI/ESD S20.20. The dissipative range controls charge slowly enough to protect personnel from grounding-fault current and fast enough to protect ESD-sensitive dispensing, fill-finish, and packaging equipment. Conductive epoxy below 1.0 × 10⁶ ohms is the exception case, specified when the room sits inside a Class I Division 2 hazardous-area classification, when the solvent list includes flammable carriers in process volumes, or when the EHS team’s S20.20 program calls for conductive based on charge-generation modeling.

It depends on which USP chapter governs the facility. USP <797> applies to sterile compounding environments — IV admixture suites, sterile compounding pharmacies, aseptic processing rooms. USP <800> applies to hazardous drug handling — oncology compounding, anti-neoplastic drug receipt and storage, anti-neoplastic prep. Pharmaceutical cleanroom ESD flooring under either chapter has to meet the cleanability, cove base, and particle-generation requirements of that chapter while also meeting S20.20 on the static-control side. The same monolithic epoxy system with integral cove base and low-VOC topcoat can satisfy both tracks when specified correctly.

Through a dual documentation track delivered as one package at closeout. The ESD side includes STM 7.1 resistance logs (point-to-point and point-to-ground), STM 97.1 and STM 97.2 body voltage data, grounding network verification, and an S20.20 program-fitness summary. The pharma side includes IQ, OQ, and PQ validation documentation, material chain of custody from manufacturer to install zone, batch certifications for primer, body coat, and topcoat, and current product data sheets for every component. The package is built during the install — not reconstructed afterward — and is structured to drop into the facility’s existing quality system rather than parallel to it.

Yes, through phased install methodology paired with atmosphere control protocols. Phase boundaries are planned around production-line shutdowns the facility has already scheduled. Temporary wall partitions and HVAC return isolation separate the work zone from active cleanrooms. The crew gowns to facility cleanroom standards, holds the work zone to defined particle, temperature, and humidity limits during prep, application, and cure, and follows the facility’s cleared-environment access protocols for ingress, egress, and material staging. Each zone moves through the 24-72 hour cure-and-test window before STM 7.1 resistance verification and return to service.

Pricing runs $3.34 to $13.55 per square foot installed, depending on system thickness, vertical, and substrate condition. The range is built from real bid data on 250+ commercial ESD projects. Pharmaceutical cleanroom work tends toward the higher end of the range because of integral cove base requirements, low-VOC topcoat premiums, phased install methodology around live operations, atmosphere-controlled install protocols, and the validation documentation overhead (IQ, OQ, PQ) that pharma quality systems require. Pre-bid walkthroughs are available within regional drive radius; remote spec review is standard for multi-region rollouts.

The closeout package includes IQ (Installation Qualification — installed system components verified against the approved spec), OQ (Operational Qualification — STM 7.1 resistance readings, STM 97.1 and 97.2 body voltage readings, ground continuity verification), and PQ (Performance Qualification — performance against intended use with cleanability protocol references and material compatibility data). Alongside the validation package, the closeout includes the standard S20.20 documentation (resistance logs, body voltage logs, program-fitness summary), material chain of custody, batch certifications, and product data sheets for every system component.

Class 5, 6, 7, and 8. Class 5 environments (fill-finish, aseptic processing) get the strictest topcoat selection, monolithic seam-free construction, integral cove base, and verified low particle generation. Class 6 and 7 allow slightly looser topcoat selection but still demand integral cove base and particle verification. Class 8 (gowning rooms, MAL and PAL vestibules) tolerates standard cove base detail but still rules out anything that sheds particles under traffic. The base system — static dissipative epoxy at 10⁶ to 10⁹ ohms with integral cove base and low-VOC topcoat — adapts across the four classes through topcoat selection and cove base detail rather than a different system per class.

Nationwide. In-house W-2 crews mobilize from 9 operating locations to project sites across the US. Craftsman has been installing industrial flooring since 1999, with pharma cleanroom ESD work running through the same phased-install methodology, manufacturer-authorized installer programs, and dual-track documentation discipline applied across the broader ESD project portfolio.